

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase IV
Sponsor : Chiesi Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Prophylactic Minimally Invasive Surfactant Evaluation
Details : Poractant Alfa is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Respiratory Distress Syndrome, Newborn.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 23, 2023
Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase IV
Sponsor : Chiesi Group
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Curosurf (Poractant Alfa) is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Respiratory Distress Syndrome.
Product Name : Curosurf
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 06, 2020
Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Chiesi Group
Deal Size : Inapplicable
Deal Type : Inapplicable
Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy
Details : Poractant Alfa is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Heart Defects, Congenital.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
November 29, 2019
Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Chiesi Group
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Curosurf (Poractant Alfa) is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Respiratory Distress Syndrome, Newborn.
Product Name : Curosurf
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 01, 2017
Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Curosurf (Poractant Alfa) is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Respiratory Distress Syndrome.
Product Name : Curosurf
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 13, 2016
Lead Product(s) : L-Alfa-Glu-Afc
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
